A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

• Status: Completed
• Trial end date: 2007-05-01

Summary

To evaluate the blood pressure lowering effect and safety of aliskiren used in combination with valsartan/hydrochlorothiazide in diabetic patients with essential hypertension, not adequately responsive to the combination of valsartan and hydrochlorothiazide

• Phase: Phase 3

Details

• Lead Sponsor: Novartis
• Treatments: Hydrochlorothiazide; Valsartan